Table 4.
Disease Name | Rank | lncRNA | Evidence | Rank | lncRNA | Evidence |
---|---|---|---|---|---|---|
Stomach cancer | 1 | MALAT1 | Lnc2Cancer, LncRNADisease | 9 | HULC | Lnc2Cancer, LncRNADisease |
2 | NEAT1 | Lnc2Cancer, LncRNADisease | 10 | CCAT2 | Lnc2Cancer, LncRNADisease | |
3 | MIR17HG | Literature [47] | 11 | KCNQ1OT1 | Lnc2Cancer | |
4 | HOTTIP | Lnc2Cancer, LncRNADisease | 12 | BCYRN1 | LncRNADisease* | |
5 | TUG1 | Lnc2Cancer, LncRNADisease | 13 | CASC2 | Lnc2Cancer, LncRNADisease | |
6 | HNF1A-AS1 | Lnc2Cancer, LncRNADisease | 14 | PANDAR | Lnc2Cancer, LncRNADisease | |
7 | XIST | Lnc2Cancer, LncRNADisease | 15 | PCAT1 | LncRNADisease* | |
8 | AFAP1-AS1 | Lnc2Cancer | ||||
Osteosarcoma | 1 | H19 | Lnc2Cancer, LncRNADisease | 9 | LINC00675 | LncRNADisease* |
2 | GAS5 | Lnc2Cancer | 10 | BCYRN1 | LncRNADisease* | |
3 | PVT1 | Lnc2Cancer | 11 | CCAT2 | Lnc2Cancer | |
4 | NEAT1 | Lnc2Cancer | 12 | CASC2 | Lnc2Cancer | |
5 | EWSAT1 | Lnc2Cancer | 13 | CCAT1 | Lnc2Cancer | |
6 | AFAP1-AS1 | Literature [48] | 14 | TP73-AS1 | Lnc2Cancer | |
7 | CDKN2B-AS1 | LncRNADisease | 15 | PCA3 | LncRNADisease* | |
8 | SPRY4-IT1 | Lnc2Cancer | ||||
Lung cancer | 1 | KCNQ1OT1 | Lnc2Cancer | 9 | IGF2-AS | Lnc2Cancer |
2 | HOTTIP | Lnc2Cancer, LncRNADisease | 10 | PCAT1 | LncRNADisease | |
3 | SPRY4-IT1 | Lnc2Cancer, LncRNADisease | 11 | CASC2 | Lnc2Cancer, LncRNADisease | |
4 | TP73-AS1 | Lnc2Cancer | 12 | ESRG | LncRNADisease* | |
5 | MIAT | Lnc2Cancer | 13 | PCA3 | LncRNADisease* | |
6 | MIR155HG | Literature [49] | 14 | SNHG12 | Lnc2Cancer | |
7 | LINC00675 | LncRNADisease* | 15 | TUSC7 | Lnc2Cancer | |
8 | SOX2-OT | LncRNADisease |
“Lnc2Cancer” means the lncRNA candidate was included in the Lnc2Cancer database. “LncRNADisease” means the candidate was included among the experimentally verified data in LncRNADisease. “LncRNADisease*” means the candidate was included among the predicted data in LncRNADisease. “Literature” means the candidate was supported in published studies.